Tyrosine kinase - Role and significance in Cancer

Manash K Paul1, Anup K Mukhopadhyay

  • 1Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S Nagar, Mohali, Punjab, India-160062.

Insights

Tyrosine kinases play crucial roles in cell signaling and cancer development. Targeting these kinases with inhibitors offers a promising therapeutic strategy for various cancers, including those involving angiogenesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Tyrosine kinases are key signaling mediators in cellular processes.
  • Aberrant tyrosine kinase activity is implicated in cancer pathophysiology.
  • Targeting tyrosine kinases is a promising strategy for cancer therapy.

Purpose of the Study:

  • To review the modes of oncogenic activation of tyrosine kinases.
  • To discuss various approaches for tyrosine kinase inhibition.
  • To explore the role of tyrosine kinase inhibitors in anti-angiogenesis therapy.

Main Methods:

  • Literature review of tyrosine kinase activation and inhibition.
  • Analysis of different drug modalities targeting tyrosine kinases.
  • Discussion of kinome knowledge for drug discovery.

Main Results:

  • Tyrosine kinases can acquire oncogenic functions through mutations or overexpression.
  • Various inhibitors, including small molecules and antibodies, are available.
  • Tyrosine kinase inhibitors show potential in anti-angiogenesis cancer therapy.

Conclusions:

  • Selective tyrosine kinase inhibitors represent a significant therapeutic advance.
  • Targeting angiogenesis via tyrosine kinases offers a novel cancer treatment approach.
  • Leveraging kinome knowledge can accelerate tyrosine kinase drug discovery.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...